Sleep Disorders Trial, Recruiting (NCT06736444)

Sleep Disorders Trial, Recruiting NCT06736444 Sponsor: University of Washington Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06736444 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 29 years old
You currently live in Washington State
You have a valid email address
You have at least moderate sleep problems, such as trouble falling asleep, staying asleep, or waking up too early (based on a standard sleep questionnaire score)
You have had at least two heavy drinking episodes in the past month (defined as 4 or more drinks within 2 hours for women or gender-diverse people, or 5 or more drinks within 2 hours for men), OR you have had at least 1 heavy drinking episode and at least 4 total drinking occasions in the past month
You have used cannabis 4 or more times in the past month
You did not take part in an earlier, related pilot study that this trial is based on

Who may not be able to join:

You do not meet all of the requirements listed above
You do not agree to continue participating after the initial consent process

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 5 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mary E Larimer, Ph.D., University of Washington

Phone: 206-543-3513

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06736444

Sponsor: University of Washington

Phase: Not Applicable

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 206-543-3513

More information: https://clinicaltrials.gov/study/NCT06736444

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 29 years old
You currently live in Washington State
You have a valid email address
You have at least moderate sleep problems, such as trouble falling asleep, staying asleep, or waking up too early (based on a standard sleep questionnaire score)
You have had at least two heavy drinking episodes in the past month (defined as 4 or more drinks within 2 hours for women or gender-diverse people, or 5 or more drinks within 2 hours for men), OR you have had at least 1 heavy drinking episode and at least 4 total drinking occasions in the past month
You have used cannabis 4 or more times in the past month
You did not take part in an earlier, related pilot study that this trial is based on

Who may not be able to join:

You do not meet all of the requirements listed above
You do not agree to continue participating after the initial consent process

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 5 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Washington

Registry

ClinicalTrials.gov

Start date

2 July 2025

Est. completion

1 April 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Insomnia Severity Index (ISI); Patient-Reported Outcomes Information System Short Form v1.0 Sleep-Related Impairment 8a (PROMIS SF8 v1.0 SRI); Quantity/Frequency/Peak Alcohol Use Index (QFP) peak item; Quantity/Frequency/Peak Alcohol Use Index (QFP) quantity item; Quantity/Frequency/Peak Alcohol Use Index (QFP) frequency item; Daily Drinking Questionnaire (DDQ); Rutgers Alcohol Problems Index

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov